Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļINDV
āļāļ·āđāļāļāļĢāļīāļĐāļąāļIndivior PLC
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 24, 2014
āļāļĩāļāļĩāđāļCiaffoni (Joseph J)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ1030
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļDec 24
āļāļĩāđāļāļĒāļđāđ234 Bath Road
āđāļĄāļ·āļāļSLOUGH
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited Kingdom
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđSL1 4EE
āđāļāļĢāļĻāļąāļāļāđ448043791090
āđāļ§āđāļāđāļāļāđhttps://www.indivior.com/en
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļINDV
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļDec 24, 2014
āļāļĩāļāļĩāđāļCiaffoni (Joseph J)
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. Ryan Preblick
Chief Financial Officer
Mr. Ryan Preblick
Chief Financial Officer
Dr. Christian Heidbreder
Chief Scientific Officer
Mr. Christian Heidbreder
Chief Scientific Officer
Dr. Christian Heidbreder
Chief Scientific Officer
Mr. Vishal Kalia
Chief Impact and Strategy Officer
Chief Impact and Strategy Officer
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.
Chief Legal Officer
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Joseph J. (Joe) Ciaffoni
Mr. Joseph J. (Joe) Ciaffoni
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. Ryan Preblick
Chief Financial Officer
Mr. Ryan Preblick
Chief Financial Officer
Dr. Christian Heidbreder
Chief Scientific Officer
Mr. Christian Heidbreder
Chief Scientific Officer
Dr. Christian Heidbreder
Chief Scientific Officer